Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2686 to 2700 of 9090 results

  1. Lisocabtagene maraleucel for treating relapsed or refractory mantle cell lymphoma [ID6695]

    Awaiting development Reference number: GID-TA11930 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Lutikizumab for treating moderate to severe hidradenitis suppurativa in people 12 years and over

    Awaiting development Reference number: GID-TA12446 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  3. Camizestrant with palbociclib for untreated oestrogen receptor-positive HER2-negative metastatic breast cancer after adjuvant endocrine treatment [ID6534]

    Awaiting development Reference number: GID-TA11686 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)

    In development Reference number: GID-NG10450 Expected publication date:  20 August 2026

    NICE guideline
    In development

  5. Self-directed automated audiometry for the diagnosis of hearing loss in adults (provisional title)

    In development Reference number: GID-HTG10909 Expected publication date: TBC

    HealthTech guidance
    In development

  6. Aggressive behaviour in people receiving NHS or social care: prevention and management

    In development Reference number: GID-NG10432 Expected publication date:  28 January 2027

    NICE guideline
    In development

  7. Autologous platelet-rich plasma (PRP) injection of the lumbar facet (zygapophyseal) joints, via the intra-articular or medial branch route, for lumbar facet joint pain

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  8. LATERA absorbable nasal implant for Nasal valve collapse causing nasal obstruction

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  9. Cryoablation for abdominal wall endometriosis

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  10. Ultrasound-guided transcervical and transvaginal radiofrequency ablation for symptomatic uterine fibroids

    In development Reference number: GID-HTG10470 Expected publication date:  18 June 2027

    HealthTech guidance
    In development

  11. Transvaginal radiofrequency ablation for symptomatic uterine fibroids

    In development Reference number: GID-HTG10538 Expected publication date: TBC

    HealthTech guidance
    In development

  12. Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]

    In development Reference number: GID-TA11454 Expected publication date: TBC

    Technology appraisal guidance
    In development

  13. Cosibelimab for treating advanced cutaneous squamous cell carcinoma [ID6663]

    Awaiting development Reference number: GID-TA11883 Expected publication date:  23 September 2027

    Technology appraisal guidance
    Awaiting development

  14. Digital technologies to support home monitoring of vision changes for people with advanced dry age-related macular degeneration: early-use assessment

    In development Reference number: GID-HTG10868 Expected publication date:  15 September 2026

    HealthTech guidance
    In development

  15. Blood-based biomarker tests for surveillance in people at risk of hepatocellular carcinoma

    In development Reference number: GID-HTG10175 Expected publication date: TBC

    HealthTech guidance
    In development